Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilesh Lomte

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of the Association of Physicians of India|February 2, 2025
Hyperglycemia as a Rare Cause of Quadriplegia: A Case ReportMahesh Shinde, Vilas Rathod, Rahul Wahatule, et al.
Endocrine Connections|April 3, 2016
Bilateral adrenal masses: a single-centre experienceNilesh Lomte, Tushar Bandgar, Shruti Khare, et al.
European Journal of Pharmacology|June 29, 2025
Assessing biosimilarity of insulin aspart injection and NovoRapid® through pharmacokinetic and pharmacodynamic comparisons in healthy volunteers: A double-blind, randomized, crossover studyRavisankar Santhanam, Sanjeev Kumar Sharma, Nilesh Lomte, et al.
Familial Cancer|November 11, 2017
Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma/paragangliomaNilesh Lomte, Sanjeet Kumar, Vijaya Sarathi, et al.
Endocrine Connections|September 16, 2017
Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing's diseasePrachi Bansal, Anurag Lila, Manjunath Goroshi, et al.
Endocrine Connections|January 8, 2020
Sellar surprises: a single-centre experience of unusual sellar massesKunal Thakkar, Swati Ramteke-Jadhav, Rajeev Kasaliwal, et al.
Diabetes, Obesity & Metabolism|February 14, 2025
Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in IndiaRakesh Sahay, Dinesh Gangwani, Manish Singh, et al.
Cureus|March 26, 2026
Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study)Nitin Kapoor, Sanjay Kalra, Arindam Naskar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of the Association of Physicians of India|February 2, 2025
Hyperglycemia as a Rare Cause of Quadriplegia: A Case ReportMahesh Shinde, Vilas Rathod, Rahul Wahatule, et al.
Endocrine Connections|April 3, 2016
Bilateral adrenal masses: a single-centre experienceNilesh Lomte, Tushar Bandgar, Shruti Khare, et al.
European Journal of Pharmacology|June 29, 2025
Assessing biosimilarity of insulin aspart injection and NovoRapid® through pharmacokinetic and pharmacodynamic comparisons in healthy volunteers: A double-blind, randomized, crossover studyRavisankar Santhanam, Sanjeev Kumar Sharma, Nilesh Lomte, et al.
Familial Cancer|November 11, 2017
Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma/paragangliomaNilesh Lomte, Sanjeet Kumar, Vijaya Sarathi, et al.
Endocrine Connections|September 16, 2017
Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing's diseasePrachi Bansal, Anurag Lila, Manjunath Goroshi, et al.
Endocrine Connections|January 8, 2020
Sellar surprises: a single-centre experience of unusual sellar massesKunal Thakkar, Swati Ramteke-Jadhav, Rajeev Kasaliwal, et al.
Diabetes, Obesity & Metabolism|February 14, 2025
Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in IndiaRakesh Sahay, Dinesh Gangwani, Manish Singh, et al.
Cureus|March 26, 2026
Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study)Nitin Kapoor, Sanjay Kalra, Arindam Naskar, et al.
Pageof 1